EUVIMEDEUVIMED entdecken
Crossref

Developing screening tools to estimate the risk of diabetic kidney disease in patients with type 2 diabetes mellitus

Xu Cao, Xiaomei Pei

Technology and Health Care · 2024

DOI: 10.3233/thc-230811 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Technology and Health Care, 2024. Verfasst von Xu Cao und 1 weiteren Autor:innen. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Diabetic Nephropathies, Glycated Hemoglobin. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Diabetic kidney disease (DKD) is an important microvascular complication of diabetes mellitus (DM). OBJECTIVE: This study aimed to develop predictive nomograms to estimate the risk of DKD in patients with type 2 diabetes mellitus (T2DM). METHODS: The medical records of patients with T2DM in our hospital from March 2022 to March 2023 were retrospectively reviewed. The enrolled patients were randomly selected for training and validation sets in a 7:3 ratio. The models for predicting risk of DKD were virtualized by the nomograms using logistic regression analysis. RESULTS: Among the enrolled 597 patients, 418 were assigned to the training set, while 179 were assigned to the validation set. Using the predictors included glycated hemoglobin A1c (HbA1c), high density lipoprotein cholesterol (HDL-C), presence of diabetic retinopathy (DR) and duration of diabetes (DD), we constructed a full model (model 1) for predicting DKD. And using the laboratory indexes of HbA1c, HDL-C, and cystatin C (Cys-C), we developed a laboratory-based model (model 2). The C-indexes were 0.897 for model 1 and 0.867 for model 2, respectively. The calibration curves demonstrated a good agreement between prediction and observation in the two models. The decision curve analysis (DCA) curves showed that the two models achieved a net benefit across all threshold probabilities. CONCLUSION: We successfully constructed two prediction models to evaluate the risk of DKD in patients with T2DM. The two models exhibited good predictive performance and could be recommended for DKD screening and early detection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Diabetic NephropathiesGlycated HemoglobinHumansMaleFemaleMiddle AgedRetrospective StudiesAgedRisk AssessmentCystatin CCholesterol, HDLNomogramsRisk FactorsMass Screening

Stichwörter der Autor:innen

Diabetic kidney diseaseglycated hemoglobin A1cnomogramrisk factortype 2 diabetes mellitus

Substanzen

Glycated HemoglobinCystatin CCholesterol, HDL

Zitieren

APA

Cao, X., & Pei, X. (2024). Developing screening tools to estimate the risk of diabetic kidney disease in patients with type 2 diabetes mellitus. Technology and Health Care. https://doi.org/10.3233/thc-230811

Vancouver

Cao X, Pei X. Developing screening tools to estimate the risk of diabetic kidney disease in patients with type 2 diabetes mellitus. Technology and Health Care. 2024. doi:10.3233/thc-230811

BibTeX
@article{Cao2024,
  author = {Cao, Xu and Pei, Xiaomei},
  title = {Developing screening tools to estimate the risk of diabetic kidney disease in patients with type 2 diabetes mellitus},
  journal = {Technology and Health Care},
  year = {2024},
  doi = {10.3233/thc-230811}
}
Kostenlos starten →